Successful Treatment with Partial Splenic Embolization in a Case of Post-transplantations Lymphoproliferative Disease with Persistent Hypersplenism.
- Author:
Mi Jin KIM
1
;
Young Il RHO
;
Eun Seok YANG
;
Kyung Rye MOON
Author Information
1. Department of Pediatrics, College of Medicine, Chosun University, Gwangju, Korea. krmoon@mail.chosun.ac.kr
- Publication Type:Case Report
- Keywords:
Partial splenic embolization (PSE);
Posttranplantations lymphoproliferative disease (PTLD)
- MeSH:
Angiography;
Child;
Fever;
Follow-Up Studies;
Herpesvirus 4, Human;
Humans;
Hypersplenism*;
Hypertension, Portal;
Immunosuppression;
Interferons;
Liver Transplantation;
Lymphatic Diseases;
Male;
Organ Transplantation;
Spleen;
Splenectomy;
Tomography, X-Ray Computed;
Transplants
- From:Korean Journal of Pediatric Gastroenterology and Nutrition
2004;7(1):92-97
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Posttranplantations lymphoproliferative disease (PTLD) is a common and life-threatening complication for soid organ transplantation associated with the use of chronic immunosuppression and Epstein-Barr virus. There is no standardized treatment algorithm, but numerous management strategies are vaiable. Partial splenic embolization (PSE) had been demonstrated to be an effetive alternatie to splenectomy for patients hypersplenism and portal hypertension. PSE has the advantages of non-invasive intervention and resolution of the complications of hypersplenism. We report the effect of the PSE in a 6-year old male liver transplantation recepient with PTLD who has undergone persistent hypersplenism post-transplant. We reduced immunosuppression agent, started antiviral agent. We started with interferon and IV globulin one month after admission. Hepatosplenomegaly and cervical lymphadenopathy were improved. But fever was not subside. We selectively embolized the lower pole of the spleen to achieve a 50~60% reduction in flow as determined by angiography. After embolization, fever subside and peripheral blood findings were improved. Follow up abdominal CT revealed reduced volume of spleen due to ischemic change and there was no multiple enlarged mesenteric lymphnode compared to preembolization state. We thick that PSE is a safe an effetive treatment modality of PTLD with persistent hypersplenism in patients twho failed to medical treatment.
